Revenue
2012
2013
2014
2015
2016
2018
2019
2020
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | $12,000 | $149,085 | $251,417 | — | $0 | $0 | $5,824 | $5,800 | $5,816 | $92,908 |
| Gross profit | — | — | — | — | — | −$2,000 | −$185,612 | $32,778 | — | — | — | — | — | — | — |
| Research & development | — | — | — | $120,000 | $96,000 | $17,000 | $114,560 | $288,813 | $282,425 | $1.0M | $398,955 | $207,246 | $21,087 | $29,007 | $50,026 |
| Operating expenses | — | — | — | — | — | — | — | — | — | — | — | $4.3M | $1.5M | $305,455 | $154,711 |
| Operating income | −$1.3M | −$1.2M | −$2.3M | −$2.0M | −$3.3M | −$8.3M | −$1.8M | $2.1M | $2.9M | $1.8M | −$724,345 | −$4.3M | −$1.5M | −$299,639 | −$61,803 |
| EBITDAderived | — | — | — | −$2.0M | −$3.3M | −$8.3M | −$1.8M | $2.2M | $2.9M | — | — | — | — | — | — |
| Net income | −$1.9M | −$2.3M | −$3.1M | −$2.6M | −$4.5M | −$8.6M | −$1.9M | $2.2M | −$2.9M | $1.9M | −$766,990 | −$4.4M | −$1.4M | −$349,145 | −$70,599 |
| Basic EPSper diluted share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$0.02 | -$0.06 | -$0.07 | -$0.12 | -$0.11 | -$0.06 | -$0.05 | -$0.03 | -$0.01 | $0.00 |
| Diluted EPSper diluted share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$0.02 | -$0.06 | -$0.07 | -$0.13 | -$0.11 | -$0.06 | -$0.05 | -$0.03 | -$0.01 | $0.00 |